3 Low P/E Ratio Stocks Poised to Surge Over 100% in 2026

Using the TipRanks Stock Screener Tool, we identified three companies that have low Price-to-Earnings (P/E) ratios and hold a "Strong Buy" consensus rating. Each stock also presents an impressive >100% upside potential within the next year, making them compelling investment choices.Claim 70% Off TipRanks This Holiday SeasonUnlock hedge-fund level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential Investing in low P/E stocks offers key benefits as these shares trade at lower prices relative to their earnings, so you pay less for each dollar of profit. This built-in margin of safety helps cushion against market downturns and potential losses. Although some investors chase high P/E stocks for explosive growth, historical data reveals that low P/E options often deliver superior returns with less risk. They typically provide higher dividends, stem from mature and stable companies, grow steadily, and show reduced price swings. Here Are This Week's Low P/E Stocks Bit Digital (BTBT) – Bit Digital stock has a P/E ratio of 5.7x, about 77% lower than its sector median. On TipRanks, the average Bit Digital price target of $5.63 implies 154.7% upside potential from current levels. Bit Digital operates as a digital asset platform with a focus on Ethereum (ETH-USD). It runs one of the world's largest institutional Ethereum-staking infrastructures, where staking involves using digital coins to help run and secure a blockchain network in exchange for rewards. This focus aligns with Ethereum's ongoing upgrades and DeFi growth, potentially providing a more scalable, income-oriented model. Exodus Movement (EXOD) – EXOD has a P/E ratio of 4.1x, about 85% lower than its sector median. On TipRanks, the average Exodus Movement price target of $40.33 implies 155.7% upside potential from current levels. Exodus Movement is a fintech firm active in the cryptocurrency and blockchain sectors, focusing on digital asset management and self-custody solutions. The company recently announced its plan to acquire W3C Corp, along with Baanx.com and Baanx US Corp, expanding its footprint in card and payments infrastructure for fintech, crypto, and enterprise clients. It also announced Exodus Pay, the first step in its shift from a self-custodial wallet to a single app for holding, spending, and sending stablecoins, while preserving self-custody. Black Diamond Therapeutics (BDTX) – BDTX has a P/E ratio of 7.2x, about 75% lower than its sector median. On TipRanks, the average BDTX price target of $8.25 implies 217.3% upside potential from current levels. Black Diamond Therapeutics is a clinical-stage biotechnology company focused on precision oncology, using its MAP mutation-family targeting approach. Key Phase 1/2 data for lead programs (notably BDTX-1535 and related assets) can create meaningful price movements based on efficacy signals and safety. Positive data or pivotal-stage progress often drives stock moves in biotech names. To find more stocks like these, explore TipRanks' Stock Screener Tool, which provides an updated list of stocks that can be filtered and scanned using various parameters.